Document is current
Any future updates will be listed below
-
Authors
Shafer, Robin L.
Bartolotti, James
Driggers, Abigail
Bojanek, Erin
Wang, Zheng
Mosconi, Matthew W.
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences (P20 GM103418)
National Center for Advancing Translational Sciences (TL1 TR002368, UL1 TR001427)
University of Kansas (Life Span Endowment - Stephen and Carolyn Schroeder Young Investigator Award)
National Institute of Mental Health (K01 MH137518, R01 MH112734)
National Institute on Aging (R21 AG065621)
National Institute of Neurological Disorders and Stroke (R01 NS121120)
University of Florida (APK Research Investment Grants Award)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54 HD090216)
- License Information
-
More Information
Article History
Received: 30 July 2024
Accepted: 13 March 2025
First Online: 16 May 2025
Declarations
:
: Adult participants provided written informed consent after a complete description of the study, in accordance with the Declaration of Helsinki. For participants under the age of 18 and adults who were under legal guardianship, a parent or legal guardian provided written informed consent on behalf of the participant, and the participant provided written assent. All study procedures were approved by the University of Kansas Medical Center Institutional Review Board (IRB#: STUDY00140269).
: Not applicable.
: MWM is PI on an investigator initiated clinical trial of behavioral inflexibility in autism funded by Acadia Pharmaceuticals. MWM and ZW received funding from Novartis Pharmaceuticals Corporation for an investigator-initiated study of Phelan McDermid Syndrome. The other authors declare that they have no competing interests.
